Tweets and Retweets by @pharma_BI and @AVIVA1950 for #NEVS at 2019 New England Venture Summit, December 4, 2019 at the Hilton in Boston, Dedham, MA, hosted by youngStartUp #NEVS
Curator: Aviva Lev-Ari, PhD, RN
Event Agenda
liked your Tweet
liked your Tweet
liked your Tweet
added you to list Employee Engagement
liked 18 of your Tweets
followed you
liked your Tweet
Great panel over 120 years of #investment #experience guiding young #entrepreneurs #NEVS19@pharma_BI
Gayatri Sarkar
who are the customers vs focus on technology and products great technology can fail because management is not aligned technologies can not get traction due to slow adoption in the market optimized valuation take partners long term cost structure
Jonathan Langer, CEO of
, spoke with
to share his predictions for #IoT trends in 2020. Read the article here: tek.io/35zIUiC. #cybersecurity
#AI strategic investment high tech ventures are long term for VC and founders milestones entrepreneurs need to meet for BC To accept valuation board controlled by Entrepreneur or by VCs convertible 15% discount negotiation power at product stage vary
Mediktor is SAAS B2B in 12 languages need $5-$15M access to Health Care
spin off @BOSTONUniversity microscopy based ExoBiew #exsosome cell communication Luminex is competitor companion diagnostics liquid Biopsy pancreatic cancer @ BIDMC interrogate exosome for therapeutics another exosome sold for $330M
who are the customers vs focus on technology and products great technology can fail because management is not aligned technologies can not get traction due to slow adoption in the market optimized valuation take partners long term cost structure
SIG.NUM SIG.RHYTHM SIG.12-LED #ECG alternative technology to 12 leads a pad with sensors
Mediktor is SAAS B2B in 12 languages need $5-$15M access to Health Care
spin off @BOSTONUniversity microscopy based ExoBiew #exsosome cell communication Luminex is competitor companion diagnostics liquid Biopsy pancreatic cancer @ BIDMC interrogate exosome for therapeutics another exosome sold for $330M
@ABIVA1950
MICROSCOPY INDUSTRY Microdissection market life science research platform open platform for Re-agent companies Cartridge removable Live Cell imaging market need $5M
micro needles for diagnostics using ISF #Interstitial System Fluid uses #glucose, #allergy, #neonatal
Eyedaptic #MACULA #degeneration #device improves #visual #acuity models to market #Low vision Market and General #Optometry #Retina MDs Virtual reality devices do not improve visual acuity
Asymmetrex stem cell counter service model need to establish cell culture lab improve SW automation establish ASTM standard achieve FDA guidance
#ALS drug targeted on the area of #breathing using a drug already approved by
phase 1 and 2 are to target the drug in higher #concentration to the breathing area
FIRST LIGHT DIAGNOSTICS antibiotics resistance C-Diff MRSA Rapid AST Anti microbial susceptibility Testing B Round pre Revenue small valuation
A DOWN TURN HURTS MOST INVESTORS FUND RAISERS don’t go for the biggest valuation if not meet numbers second trench negatively affected same for valuation technology progresses support Series A, B
#VC #Investors are presenting the #pulse #investment #market #institutionalInvestors #Exits #IPO by #M&A #women #leaders #platform #investment #corporate #technology #gamechanging #Entrepreneur #raisingfunds 12-18 month #economic #downturn #deals
device requires less energy than LVAD no support continuous mode pulsitile mode Euro16M needed to complete animal trials
micro needles for diagnostics using ISF #Interstitial System Fluid uses #glucose, #allergy, #neonatal
device requires less energy than LVAD no support continuous mode pulsitile mode Euro16M needed to complete animal trials
A DOWN TURN HURTS MOST INVESTORS FUND RAISERS don’t go for the biggest valuation if not meet numbers second trench negatively affected same for valuation technology progresses support Series A, B
#VC #Investors are presenting the #pulse #investment #market #institutionalInvestors #Ecits #IPO by #M&A #women #leaders #platform #investment #corporate #technology #gamechanging #Entrepreneur #raisingfunds 12-18 month #economic #downturn #deals
Travera Solutions a #biomarker for all the #Cancer drugs approved by
#Suspended #Micro channel #Resonator SMR invented
IVD and Lab developed test LDT amazing innovation
micro needles for diagnostics using ISF #Interstitial System Fluid uses #glucose, #allergy, #neonatal
A DOWN TURN HURTS MOST INVESTORS FUND RAISERS don’t go for the biggest valuation if not meet numbers second trench negatively affected same for valuation technology progresses support Series A, B
#VC #Investors are presenting the #pulse #investment #market #institutionalInvestors #Ecits #IPO by #M&A #women #leaders #platform #investment #corporate #technology #gamechanging #Entrepreneur #raisingfunds 12-18 month #economic #downturn #deals
SIG.NUM SIG.RHYTHM SIG.12-LED #ECG alternative technology to 12 leads a pad with sensors
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
vaishnavee24
zraviv06
zs22
Leave a Reply